New developments in the treatment of pediatric allergic rhinitis and conjunctivitis.
Pediatr Ann
; 43(8): e192-200, 2014 Aug.
Article
in En
| MEDLINE
| ID: mdl-25102489
ABSTRACT
The primary care physician is the first line of treatment for allergic rhinitis, which affects approximately one-fourth of children in the United States. There is an increasing trend toward self-management by patients or parents due to high-deductible insurance plans and the over-the-counter availability of allergy medications. The primary care physician can offer guidance on appropriate selection of medications and potential adverse effects. Vitamin D deficiency has been proposed as a potential contributing factor in patients with allergic diseases, and studies are underway to determine whether supplementation with vitamin D is helpful for these conditions. Sublingual immunotherapy has recently received US Food and Drug Administration approval for grass and ragweed allergens; many children will be interested in this alternative to allergy shots. The relative advantages and disadvantages of sublingual vs subcutaneous immunotherapy are discussed.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Primary Health Care
/
Vitamin D Deficiency
/
Allergens
/
Rhinitis, Allergic, Perennial
/
Conjunctivitis
/
Sublingual Immunotherapy
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Guideline
Limits:
Child
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Pediatr Ann
Year:
2014
Document type:
Article